Mark S. Forman - Aug 16, 2021 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Edgar Cale, Attorney-in-Fact
Stock symbol
PASG
Transactions as of
Aug 16, 2021
Transactions value $
-$1,589
Form type
4
Date filed
2/13/2024, 07:34 PM
Next filing
Apr 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PASG Common Stock Options Exercise +5K +11.05% 50.3K Feb 10, 2024 Direct F1
transaction PASG Common Stock Sale -$1.59K -1.64K -3.26% $0.97 48.6K Feb 13, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Employee Stock Option (right to buy) Award $0 +130K $0.00 130K Aug 16, 2021 Common Stock 130K $10.84 Direct F3
transaction PASG Employee Stock Option (right to buy) Award $0 +25K $0.00 25K Feb 10, 2022 Common Stock 25K $4.52 Direct F4
transaction PASG Restricted Stock Unit Award $0 +15K $0.00 15K Feb 10, 2022 Common Stock 15K Direct F1, F5
transaction PASG Restricted Stock Unit Options Exercise $0 -5K -33.33% $0.00 10K Feb 10, 2024 Common Stock 5K Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2 The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a "sell to cover" transaction.
F3 The stock option vests as to 25% of the total shares on August 16, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F4 The stock option vests as of 1/48 of the total shares monthly beginning on March 10, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F5 1/3 of the RSUs will vest on February 10, 2024 and 2/3 of the RSUs will vest on February 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date.